Firms

Athensmed

Athensmed

Helsinki, Finland

athensmed.fi

Athensmed is a first-generation, family-owned Finnish healthcare investment company and family office founded and led by physician-investor Kustaa Piha. The legal entity Athensmed Oy, business ID2602802-8, is registered in Helsinki; Finland’s official PRH/YTJ API confirms the same domain and May31,2014 trade-register entry, distinct from its February3,2014 business-ID issuance and from Greek AthensMed clinic namesakes. It invests in early-stage health technologies and healthcare services, combining financial investment with active ownership, operating support and an emphasis on accessibility, health equality and measurable social impact. Its current published team consists of CEO/founder Kustaa Piha and investment manager Sonia Singh. Portfolio examples include Sooma’s non-invasive brain-stimulation technology, MVision AI radiotherapy-planning software, Klinik’s AI triage, Finnadvance’s biomimetic drug-development models, Biospectal smartphone-based monitoring and Brinter3D bioprinting. The public list also includes healthcare-service holdings and separately identifies realized exits. Athensmed participated in Sooma’s completed EUR1M equity financing announced December18,2019; the separate EUR250K Business Finland grant is not combined into its equity check. No personal investment by Kustaa Piha is inferred from the firm’s institutional participation. No externally raised LP fund, closed fund corpus, manager AUM or individual allocation was verified; the founder’s more-than50 investments includes direct/portfolio-firm activity and is not represented as50 Athensmed cash transactions. Grants, charitable commitments and healthcare claims are distinguished from completed venture financings or independent regulatory findings.

Founded
2014
Type
Venture capital

Funds0

No funds on record yet.

Team

Operations and support

Kustaa PihaKustaa PihaFounder and Chief Executive Officer
Sonia SinghSonia SinghInvestment Manager

Co-investing

Investments